These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 21907959)
21. Topical Therapy With Imiquimod for Vaginal Intraepithelial Neoplasia: A Case Series. Policiano AC; Lopes JP; Barata SA; Colaço AM; Calhaz-Jorge C J Low Genit Tract Dis; 2016 Jul; 20(3):e34-6. PubMed ID: 27158879 [No Abstract] [Full Text] [Related]
22. Female genital warts: global trends and treatments. Gall SA Infect Dis Obstet Gynecol; 2001; 9(3):149-54. PubMed ID: 11516064 [TBL] [Abstract][Full Text] [Related]
23. Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases. Rosenblatt A; de Campos Guidi HG Int J STD AIDS; 2012 Dec; 23(12):909-10. PubMed ID: 23258837 [TBL] [Abstract][Full Text] [Related]
24. An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia. Hampson L; Martin-Hirsch P; Hampson IN Expert Opin Investig Drugs; 2015; 24(12):1529-37. PubMed ID: 26457651 [TBL] [Abstract][Full Text] [Related]
25. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study. Saiag P; Bauhofer A; Bouscarat F; Aquilina C; Ortonne JP; Dupin N; Mougin C Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962 [TBL] [Abstract][Full Text] [Related]
27. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. Gilson R; Nugent D; Bennett K; Doré CJ; Murray ML; Meadows J; Haddow LJ; Lacey C; Sandmann F; Jit M; Soldan K; Tetlow M; Caverly E; Nathan M; Copas AJ Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189 [TBL] [Abstract][Full Text] [Related]
28. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys. Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic approaches to genital warts. Beutner KR; Ferenczy A Am J Med; 1997 May; 102(5A):28-37. PubMed ID: 9217660 [TBL] [Abstract][Full Text] [Related]
30. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. Tyring SK; Arany I; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB J Infect Dis; 1998 Aug; 178(2):551-5. PubMed ID: 9697742 [TBL] [Abstract][Full Text] [Related]
31. Eradication and reinfection of human papillomavirus after photodynamic therapy for cervical intraepithelial neoplasia. Ichimura H; Yamaguchi S; Kojima A; Tanaka T; Niiya K; Takemori M; Hasegawa K; Nishimura R Int J Clin Oncol; 2003 Oct; 8(5):322-5. PubMed ID: 14586759 [TBL] [Abstract][Full Text] [Related]
32. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906 [TBL] [Abstract][Full Text] [Related]
33. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Beutner KR; Tyring SK; Trofatter KF; Douglas JM; Spruance S; Owens ML; Fox TL; Hougham AJ; Schmitt KA Antimicrob Agents Chemother; 1998 Apr; 42(4):789-94. PubMed ID: 9559784 [TBL] [Abstract][Full Text] [Related]
34. New approach to managing genital warts. Lopaschuk CC Can Fam Physician; 2013 Jul; 59(7):731-6. PubMed ID: 23851535 [TBL] [Abstract][Full Text] [Related]
35. Using imiquimod for genital warts in female patients. Cox JT; Petry KU; Rylander E; Roy M J Womens Health (Larchmt); 2004 Apr; 13(3):265-71. PubMed ID: 15130255 [TBL] [Abstract][Full Text] [Related]
37. Changes in strategies for human papillomavirus genital disease. Apgar BS Am Fam Physician; 1997 Apr; 55(5):1545-6, 1548. PubMed ID: 9105185 [No Abstract] [Full Text] [Related]
38. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Wagstaff AJ; Perry CM Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284 [TBL] [Abstract][Full Text] [Related]
39. [Assessment of the treatment with imiquimod in persistent infection by human papillomavirus with the polimerase chain reaction method]. Hernández Quijano T; Illanes Aguiar B; Salas Linares N; Alarcón Romero Ldel C; Hernández Valencia M Ginecol Obstet Mex; 2006 Jun; 74(6):317-26. PubMed ID: 16970118 [TBL] [Abstract][Full Text] [Related]
40. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial. Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]